Listed Companies' Financial Results: Overcome Headwinds with Proactive Strategies
Listed companies have been reporting strong financial results. However, this fiscal year, the situation has changed significantly, and they are likely to face headwinds from the negative impact of tariff measures by U.S. President Donald Trump.
It is hoped that companies will not fall into a defensive posture, but rather implement proactive strategies to continue to grow, and will achieve high wage increases.
Almost all companies listed on the Tokyo Stock Exchange have announced their earnings for the year ending March 31, 2025. The combined net profits of companies that make up the Tokyo Stock Price Index (TOPIX), excluding firms in the financial sector, hit a record high for the fourth consecutive year.
In addition to the strong performance of semiconductor-related companies due to increased demand for chips, corporate performance in the automobile industry also remained firm. The total net profits of the manufacturing sector amounted to about ¥22.7 trillion.
The railroad sector, which is benefiting from the full-fledged recovery of visitors to Japan, and information technology-related services, which are experiencing strong demand for investment in digital technology, also performed well. Mainly for these reasons, non-manufacturing companies' net profits increased.
It can be said that the trend of listed companies achieving high growth and giving it back in the form of higher wages has been making steady progress.
The concern is corporate performance for the fiscal year ending March 31, 2026, when the impact of the U.S. government's high tariff policy will be felt fully. Forty percent of the about 1,000 companies forecast a decrease in profits.
In particular, the damage to the automobile industry, a key industry in Japan, is expected to be large.
Toyota Motor Corp. has estimated that tariffs will be a factor in a ¥180 billion decline in operating profit for the two months of April and May. Honda Motor Co. also forecast an annual decline of ¥650 billion in operating profit due to tariffs. Four out of the seven major automakers have disclosed earnings forecasts. According to them, their total net profits are expected to fall 40% from the previous fiscal year.
The automobile industry has led the way in high-level wage increases for three consecutive years until this year's shunto spring wage negotiations. If momentum for higher wages wanes, the transition to a growth-oriented economy, in which wages and investment both increase, could be derailed.
With about ¥600 trillion in corporate internal reserves, companies should have the capacity to weather the adverse economic conditions. They need to continue their efforts to keep wage increases flowing.
With the outlook becoming increasingly uncertain, many companies have begun to slash their workforces, even though they are in the black. The number of listed companies offering early or voluntary retirement is rapidly increasing. Panasonic Holdings Corp. has announced that it will cut a total of about 10,000 jobs in Japan and overseas.
On the other hand, some companies are anticipating growth despite the headwinds. Ajinomoto Co. forecast its highest profit in three years for the fiscal year ending March 31, 2026, on the back of growth in electronic materials for semiconductors, among other factors. It is hoped that companies will look for new growth areas, rather than relying on restructuring.
There is a possibility that the protectionist stance of the United States will be prolonged. It also will be important to reduce dependence on the United States and develop new sales channels.
(From The Yomiuri Shimbun, May 23, 2025)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Mainichi
39 minutes ago
- The Mainichi
Tokyo stocks drop on concern over changing US tariff policies
TOKYO (Kyodo) -- Tokyo stocks fell Monday on selling fueled by growing concerns over ever-changing U.S. tariff policies after President Donald Trump announced a doubling of levies on steel and aluminum. The 225-issue Nikkei Stock Average ended down 494.43 points, or 1.30 percent, from Friday at 37,470.67. The broader Topix index finished 24.28 points, or 0.87 percent, lower at 2,777.29. On the top-tier Prime Market, decliners were led by rubber product, precision instrument and transportation equipment issues. The U.S. dollar weakened to around the 143 yen line in Tokyo as the Japanese currency, seen as a safe-haven asset, was bought on growing worries about U.S.-China trade tensions after Trump accused China of violating a trade deal, dealers said. Stocks dropped as fears of a global economic slowdown grew after Trump said Friday that he will raise tariffs on steel and aluminum imports to 50 percent from 25 percent imposed by his administration earlier this year. "The flip-flops in his policy make it difficult for companies to make investment decisions in the long run, possibly causing them to hold back on capital spending," said Masahiro Yamaguchi, head of investment research at SMBC Trust Bank. In addition to Trump's announcement of higher tariff rates on steel and aluminum, the concerns over rekindled U.S.-China trade frictions also weighed on the market, brokers said. "The optimistic mood in May likely changed this month," as prolonged uncertainty will increasingly weigh on the economy and have a negative impact on risk assets, Yamaguchi said.
Japan Times
an hour ago
- Japan Times
Trump's WHO withdrawal could cost the U.S. dearly
While the COVID-19 pandemic is firmly in the past for many Americans, U.S. households continue to bear the costs of infectious-disease outbreaks. A few months ago, the price of eggs in the United States soared to a record high, largely owing to the spread of H5N1 bird flu. Since March 2024, the virus has ravaged U.S. chicken farms, leading to tens of millions of poultry deaths from infection or culling. More ominously, at least 70 human cases of bird flu have been identified in the U.S., with one death reported in Louisiana. In a recent report about enhancing the response to H5N1 in America and globally, the Global Virus Network, a consortium of the world's top virologists, warned of 'the terrible consequences of underreacting to current threats.' But while bird flu poses the most immediate risk to Americans, it is by no means the only one. Virulent infectious-disease outbreaks in other countries, such as mpox in the Democratic Republic of the Congo, Ebola in Uganda, Marburg in Tanzania and multicountry outbreaks of cholera do not respect borders and thus are a threat to people everywhere — including in the U.S. Without the efforts of the World Health Organization to contain these outbreaks, the risks of wider transmission would be much greater. This underscores the need for a global agency like the WHO to supervise cross-border cooperation — and the shortsightedness of U.S. President Donald Trump's decision to withdraw the U.S. from the organization. Despite being the world's richest and most powerful country, America is not immune to another COVID-19-style calamity and abandoning multilateralism and neglecting pandemic preparedness (such as the stockpiling of treatments and vaccines) will make it all the more vulnerable. One might think that the deadly spread of COVID-19, prolonged by the emergence of new virus strains, would convince policymakers to strengthen the world's public-health architecture — especially as experts warn that future pandemics could be even worse. But with other leaders indicating that they may follow Trump's example and leave the WHO, the resources for pandemic prevention and control could dwindle to the point that global outbreaks become more frequent and difficult to overcome. If Trump follows through with the move, his administration will become increasingly isolated and impotent. American officials, including at U.S. military installations abroad, will lose access to the WHO-led and -facilitated global networks that collect and share information about infectious-disease threats and respond to outbreaks. Moreover, the U.S. government will have no say in developing new solutions (which will almost invariably be less effective) for controlling the spread of diseases across borders — including its own. Trump has suggested that he may change his mind, presumably if the grievances set out in his executive order to withdraw the U.S. from the organization are addressed. This implies that the WHO should apply pressure on China to identify the pandemic's origins. WHO Director-General Tedros Adhanom Ghebreyesus, for his part, has refused to accept the Chinese government's prevarications. If Trump can propose a way to determine the cause of COVID-19, I am sure that the WHO's leadership would gladly hear it. Trump's second condition is that the WHO undertake reforms and use its resources more effectively at the local level, with a greater focus on stopping the spread of infectious diseases. This is a demand that can and should be met. To that end, Tedros has already promised more targeted use of funds and implemented other measures to transform the organization. In addition, under Tedros, the WHO has transformed the way it raises funds. Its member states have sharply increased their annual contributions and it has diversified its donor base to share the funding load more widely. This is all part of the WHO's drive to be more sustainably financed, a plan launched as part of Tedros's effort to transform the organization's operations after he took office in 2017. Back then, he and member states assessed that the departure of a major donor could leave the WHO's programs and independence vulnerable to funding shocks. Who knew it would be the U.S. But, had those changes not been made, we can only imagine how much more challenging the WHO's current financial situation would be. The Trump administration should welcome these changes, not least because it benefits from having a seat at the table. If the U.S. ultimately abandons the WHO, developing evidence-based guidance and regulations for chronic-disease prevention and management will be significantly harder, undermining the administration's goal of addressing America's chronic-disease epidemic. The U.S. will also no longer be a part of the WHO's medicine prequalification process, a program that opens a host of new markets for drug producers in a cost-effective manner. Instead, U.S. pharmaceutical companies will be forced to sell their prequalified products to each country individually, putting them at risk of losing access to highly profitable multibillion dollar markets. Twenty-first-century trends — including more mobility and international travel, greater urbanization and increasing human encroachment on nature — fuel the global spread of infectious diseases, to the detriment of everyone. U.S. officials would be better positioned to protect their citizens if they joined — and perhaps even led — a discussion on how the WHO and other global health organizations, such as Gavi, the Vaccine Alliance and the Global Fund to Fight AIDS, Tuberculosis, and Malaria, can meet the world's needs. One such initiative, in which the U.S. had been a strong partner until Trump took office, was to negotiate a WHO Pandemic Agreement, which WHO member states adopted by consensus at the World Health Assembly on May 20. This historic compact, based on the principles of equity, collaboration and the reaffirmation of national sovereignty in public-health decision-making, will make the world safer from future pandemics. The U.S., bolstered by its world-class medical professionals and substantial public investment in medical research, has long exerted considerable influence on global health priorities. But withdrawing from the WHO places America on the outside, unable to shape the agency's policy agenda and reforms. When the next pandemic strikes, the U.S. will be left watching from the sidelines, as the WHO and its remaining member countries manage the global response and pick up the pieces as they see fit. Gordon Brown, a former prime minister of the United Kingdom, is U.N. Special Envoy for Global Education and Chair of Education Cannot Wait. © Project Syndicate, 2025.
NHK
an hour ago
- NHK
China rejects Trump's claim it violated trade agreement
US President Donald Trump's claim that China violated a trade agreement has triggered strong pushback from officials in Beijing. The Commerce Ministry called the accusation "groundless." The agreement was reached during talks in Geneva in May. It includes reducing the additional tariffs the US and China imposed on each other by 115 percentage points. Trump claimed on social media on Friday that China was breaching the deal. US officials argue that China is holding up exports of rare earths, among other issues. China's Commerce Ministry rejected that accusation in a statement on Monday. It said Beijing has actively upheld the Geneva agreement in a responsible manner. The statement accused the US side of introducing a series of discriminatory measures against China after the agreement was reached. Citing Washington's plan to revoke the visas of Chinese students, it said the United States was gravely harming China's legitimate rights. The statement also said that if the US insists on going its own way and continues to undermine China's interests, Beijing will resolutely take forceful measures to safeguard its legitimate rights and interests.
